The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum

This publication has 181 references indexed in Scilit:

• Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia
  Archives of Gynecology and Obstetrics, 2023
• Evaluation of Activated Protein C Resistance Using Thrombin Generation Test
  2023
• D‐dimer testing in clinical practice in the era of COVID‐19
  Research and Practice in Thrombosis and Haemostasis, 2022
• Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system
  Research and Practice in Thrombosis and Haemostasis, 2022
• VTE risk assessment in pregnancy
  Research and Practice in Thrombosis and Haemostasis, 2019
• Epidemiology of venous thromboembolism (VTE) associated with pregnancy
  Birth Defects Research Part C: Embryo Today: Reviews, 2015
• Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality
  American Journal of Obstetrics and Gynecology, 2006
• Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives
  American Journal of Obstetrics and Gynecology, 1995
• Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study
  International Journal of Clinical and Laboratory Research, 1994
• Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy
  Thrombosis Research, 1989